Astrazeneca Plc (AZN)
$54.17
0.00 (0.00%)
19:43 EDT
AZN Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
137.23B
PE Ratio
48.90
EPS
1.107848
Volume (Avg. Vol.)
Day's Range
54.17 - 54.17
52-Week Range
36.15 - 64.94
Dividend & Yield
1.37 (2.53%)
AZN Stock Predictions, Articles, and Astrazeneca Plc News
- From InvestorPlace
- From the Web
What Will the Stock Market Do Today? 3 Big Stories to Watch.
What will the stock market do today? Investors will focus on Warren's wealth tax, EV stocks and Covid-19 hopes. Here's what to know.
7 Pharmaceutical Stocks With Compelling Pipelines
Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.
When the Travel Sector Is Set to Take Off
The travel and hospitality industry is a sector that should thrive in 2021. In fact, travel is one of Eric Fry's four "Power Trends" in the new year.
Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today
Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans.
Healthcare Stocks: How AI Is Helping in the Fight Against COVID-19
There’s a lot of potential in the healthcare space thanks to new technologies, and we believe that we have found the best high-quality stocks to play the massive upside.
8 Value Stocks That Could Perform Surprisingly Well In 2021
With growth names still flying high, value stocks to buy doesn’t exactly inspire excitement. Nevertheless, it could be the most prudent choice ahead of an uncertain 2021.
Vaccine News May Make AstraZeneca Stock Seem Worth a Shot, But It’s Not
The U.K. greenlighted AstraZeneca's vaccine, but don't take that as a signal to buy. AZN stock looks terrible.
Why the New Covid-19 Strain Matters for Pfizer Stakeholders
With Pfizer delivering Covid-19 vaccines, PFE stock appears to be the pandemic’s winner. However, a new strain of SARS-CoV-2 and fresh competition may apply some pressure.
The Question to Ask About COVID-19 Vaccine Stocks
The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started. Here's where to focus instead.
The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure
Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.
7 Short-Term Stocks to Trade as a Present to Yourself Before the Year Ends
Investors still have a few weeks left of trading, after spectacular returns so far in the year. Here are 7 short-term ideas.
How to Invest in a Post-COVID World
Buying stocks that have been hit by a serious but solvable problem, can lead to extraordinary gains when things work out positively.
Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand
As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.
3 Big Reasons the Dow Just Crossed 30K
The Dow just crossed 30,000 for the first time ever. Dive in to learn more about the three reasons behind this record move.
3 Pharmaceutical Stocks to Buy in November
Here are pharmaceutical stocks for November 2020 with a focus on companies that are close to delivering a vaccine against Covid-19.
Don’t Be Fazed by the Recent Market Volatility
Don't be misled by worrisome headlines by the fearmongering media. The market should only get better from here. Use any weakness to pick up high quality stocks with strong fundamentals.
4 Safe Stocks to Lock Down Profits
As market valuations look stretched, it's a good time to consider exposure to some low beta safe stocks that feature dependable dividends.
7 Companies to Invest in That Pivoted Perfectly in the Pandemic
The novel coronavirus pandemic produced some clear winners. And here are seven companies to invest in that adjusted well to the "new normal."
10 Stocks For Beginners To Buy Today For Profits Tomorrow
The novel coronavirus and resulting quarantine led a lot of new investors to join in the markets. Here are 10 stocks for beginners to buy.
7 Coronavirus Vaccine Stocks to Watch as Approval Nears
By
Thomas Niel
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now.
AstraZeneca (NYSE:AZN)
CureVac (NASDAQ:CVAC)
GlaxoSmithKline (NYSE:GSK)
Inovio (NASDAQ:INO)
Johnson & Johnson (NYSE:JNJ)
Moderna (NASDAQ:MRNA)
Novavax (NASDAQ:NVAX)

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold